Sn — you need to keep reading .
This is the entire point ,written about in here this week alon—that there are no real competitors to bisantrene.
Bisantrene was better than a country mile compared to nos 2 through 6 etc in the clinical study .
Much better , remarkably so to coin Dr Cullity (RAC Chairman) favourite word . And brequinar , the no 2 compound , was trialed in the past for organ replacement therapy —apart from dangerous immune-suppression actions which makes it unsuited as a cancer treatment drug , it does not have consistent drug dosing regime ability across patients, with wildly varying drug dosages for effects between individual patients and for when negative reactions occur . In short = not good . Known significant problems with the no. 2 FTO inhibitor agent in the COH study , which performed significantly lower than bisantrene anyway.
Other drug compounds — *have not been trialed in people , not even to phase 1 **. So safety unknown, and dose profiles etc are not known , let alone therapeutic effects !
Bisantrene has known safety , and dose regimes are known and understood.
Bisantrene has been through over 40 clinical trials , inc last years Sheba trial ; and most importantly has proven efficacy and effectiveness even in highly refractory cases ..and very advanced cancers(relapsed , not responsive to existing treatments inc anthracyclines resistance ) - which we now realise , that these cancers have associations with FTO protein over -expression![]()
- Forums
- ASX - By Stock
- RAC
- Pillar 1 - FTO (new thread)
Pillar 1 - FTO (new thread), page-403
-
- There are more pages in this discussion • 2,587 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.57 |
Change
-0.035(2.18%) |
Mkt cap ! $272.6M |
Open | High | Low | Value | Volume |
$1.69 | $1.69 | $1.55 | $435.0K | 270.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 1100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 1.570 |
1 | 1104 | 1.565 |
3 | 5375 | 1.560 |
3 | 3669 | 1.550 |
2 | 2400 | 1.540 |
Price($) | Vol. | No. |
---|---|---|
1.585 | 1100 | 1 |
1.590 | 3861 | 2 |
1.595 | 550 | 1 |
1.620 | 2815 | 1 |
1.650 | 1000 | 1 |
Last trade - 14.26pm 30/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online